Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma

BACKGROUND: The aim of the study reported here was to evaluate the feasibility and safety of raltitrexed and nedaplatin with concurrent radiotherapy in patients with unresectable, locally advanced esophageal squamous cell carcinoma (ESCC). METHODS: Eligible patients were adults with newly diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Xiangnan, Li, Jing, Zhou, Han, Zhang, Meng, Jiang, Changchen, Shen, Zetian, Zhu, XiXu, Li, Aomei, Che, Yuxin, Wu, Tiancong, Wang, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004679/
https://www.ncbi.nlm.nih.gov/pubmed/31977864
http://dx.doi.org/10.1097/MD.0000000000018732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004679/
https://www.ncbi.nlm.nih.gov/pubmed/31977864
http://dx.doi.org/10.1097/MD.0000000000018732

Ejemplares similares